Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Robert McCorkle

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Biomedicines|January 15, 2021
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian CancerDavid Schweer, J Robert McCorkle, Jurgen Rohr, et al.
Cancers|April 13, 2024
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian CancerJ Robert McCorkle, Rebecca Ahn, Connie D Cao, et al.
Diagnostics (Basel, Switzerland)|February 27, 2020
Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant <i>BRCA1</i> Mutant Ovarian CellsBrian T Burgess, Abigail M Anderson, J Robert McCorkle, et al.
Cancers|April 30, 2021
KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung CancerKristen S Hill, Anthony McDowell, J Robert McCorkle, et al.
Diagnostics (Basel, Switzerland)|March 3, 2021
Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer TreatmentAnthony McDowell, Kristen S Hill, J Robert McCorkle, et al.
ACS Omega|August 29, 2019
Cell-Derived Vesicles for in Vitro and in Vivo Targeted Therapeutic DeliveryAaron A Snell, Khaga R Neupane, J Robert McCorkle, et al.
Plos One|August 4, 2021
Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancerJ Robert McCorkle, Justin W Gorski, Jinpeng Liu, et al.
Frontiers in Oncology|January 30, 2023
Human macrophage-engineered vesicles for utilization in ovarian cancer treatmentDavid Schweer, Namrata Anand, Abigail Anderson, et al.
Chemmedchem|November 7, 2022
Mithplatins: Mithramycin SA-Pt(II) Complex Conjugates for the Treatment of Platinum-Resistant Ovarian CancersSuhas S Bhosale, Abhisek Mandal, Caixia Hou, et al.
Journal of Medicinal Chemistry|February 20, 2025
Chemoproteomic Profiling of a Carbon-Stabilized Gold(III) Macrocycle Reveals Cellular Engagement with HMOX2Sailajah Gukathasan, Chibuzor Olelewe, Libby Ratliff, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biomedicines|January 15, 2021
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian CancerDavid Schweer, J Robert McCorkle, Jurgen Rohr, et al.
Cancers|April 13, 2024
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian CancerJ Robert McCorkle, Rebecca Ahn, Connie D Cao, et al.
Diagnostics (Basel, Switzerland)|February 27, 2020
Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant <i>BRCA1</i> Mutant Ovarian CellsBrian T Burgess, Abigail M Anderson, J Robert McCorkle, et al.
Cancers|April 30, 2021
KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung CancerKristen S Hill, Anthony McDowell, J Robert McCorkle, et al.
Diagnostics (Basel, Switzerland)|March 3, 2021
Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer TreatmentAnthony McDowell, Kristen S Hill, J Robert McCorkle, et al.
ACS Omega|August 29, 2019
Cell-Derived Vesicles for in Vitro and in Vivo Targeted Therapeutic DeliveryAaron A Snell, Khaga R Neupane, J Robert McCorkle, et al.
Plos One|August 4, 2021
Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancerJ Robert McCorkle, Justin W Gorski, Jinpeng Liu, et al.
Frontiers in Oncology|January 30, 2023
Human macrophage-engineered vesicles for utilization in ovarian cancer treatmentDavid Schweer, Namrata Anand, Abigail Anderson, et al.
Chemmedchem|November 7, 2022
Mithplatins: Mithramycin SA-Pt(II) Complex Conjugates for the Treatment of Platinum-Resistant Ovarian CancersSuhas S Bhosale, Abhisek Mandal, Caixia Hou, et al.
Journal of Medicinal Chemistry|February 20, 2025
Chemoproteomic Profiling of a Carbon-Stabilized Gold(III) Macrocycle Reveals Cellular Engagement with HMOX2Sailajah Gukathasan, Chibuzor Olelewe, Libby Ratliff, et al.
Pageof 2